Related Experiment Video
Updated: Dec 27, 2025

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
Published on: May 15, 2018
mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update
Fiona Limanaqi1, Francesca Biagioni2, Carla Letizia Busceti2
1Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.
Abstract:
Recent evidence suggests that autophagy impairment is implicated in the epileptogenic mechanisms downstream of mTOR hyperactivation. This holds true for a variety of genetic and acquired epileptic syndromes besides malformations of cortical development which are classically known as mTORopathies. Autophagy suppression is sufficient to induce epilepsy in experimental models, while rescuing autophagy prevents epileptogenesis, improves behavioral alterations, and provides neuroprotection in seizure-induced neuronal damage. The implication of autophagy in epileptogenesis and maturation phenomena related to seizure activity is supported by evidence indicating that autophagy is involved in the molecular mechanisms which are implicated in epilepsy. In general, mTOR-dependent autophagy regulates the proliferation and migration of inter-/neuronal cortical progenitors, synapse development, vesicular release, synaptic plasticity, and importantly, synaptic clustering of GABAA receptors and subsequent excitatory/inhibitory balance in the brain. Similar to autophagy, the ubiquitin-proteasome system is regulated downstream of mTOR, and it is implicated in epileptogenesis. Thus, mTOR-dependent cell-clearing systems are now taking center stage in the field of epilepsy. In the present review, we discuss such evidence in a variety of seizure-related disorders and models. This is expected to provide a deeper insight into the molecular mechanisms underlying seizure activity.
Insights
Impaired autophagy, a process regulated by mTOR, is linked to epilepsy. Restoring autophagy can prevent seizures, improve behavior, and protect the brain from seizure damage.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Autophagy impairment is increasingly linked to epileptogenesis, particularly in mTORopathies.
- This cellular process plays a role in various genetic and acquired epilepsy syndromes.
Purpose of the Study:
- To review the role of autophagy and the ubiquitin-proteasome system in epilepsy.
- To explore mTOR-dependent cell-clearing mechanisms in seizure-related disorders.
Main Methods:
- Review of existing evidence on autophagy and epilepsy.
- Analysis of experimental models demonstrating the effects of autophagy modulation.
Main Results:
- Autophagy suppression can induce epilepsy, while its restoration prevents epileptogenesis and offers neuroprotection.
- mTOR-dependent autophagy regulates crucial neuronal functions including progenitor cell migration, synapse development, and excitatory/inhibitory balance via GABAA receptors.
Conclusions:
- mTOR-dependent autophagy and the ubiquitin-proteasome system are central to epileptogenesis.
- Understanding these cell-clearing systems offers new insights into epilepsy mechanisms and potential therapeutic targets.
More Related Videos
09:39Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...